Cargando…
A Case of Peritoneal Tuberculosis Developed after Infliximab Therapy for Refractory RA
Recently, interferon gamma releasing assay has been recommended to compensate the tuberculin skin test (TST) for screening for latent tuberculosis infection (LTBI). Although it improved the detection of LTBI before treatment with tumor necrosis factor blocker, its application to immune suppressed pa...
Autores principales: | Min, Ji-Yeon, Bang, So-Young, Min, Seung-Yeon, Lee, Dae-Sung, Kim, Bo-Sang, Kim, Jeong-Eun, Lee, Eun-Sung, Pyo, Ju-Yeon, Sohn, Jang-Won, Kim, Tae-Hyung, Lee, Hye-Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492425/ https://www.ncbi.nlm.nih.gov/pubmed/23166560 http://dx.doi.org/10.4046/trd.2012.73.4.234 |
Ejemplares similares
-
Infliximab Treatment for Refractory Kawasaki Disease in Korean Children
por: Song, Min Seob, et al.
Publicado: (2010) -
Paradoxical response during antituberculous therapy in a patient discontinuing infliximab: a case report
por: Yoon, Young Kyung, et al.
Publicado: (2009) -
Tuberculosis Relief Belt Supporting Project (Tuberculosis Patient Management Project for Poverty Group)
por: Kim, Jae Kyoung, et al.
Publicado: (2018) -
Refractory Duodenal Crohn's Disease Successfully Treated with Infliximab
por: Kim, You Lim, et al.
Publicado: (2014) -
Co-administration of Lactobacillus gasseri KBL697 and tumor necrosis factor-alpha inhibitor infliximab improves colitis in mice
por: Han, Dae Hee, et al.
Publicado: (2022)